Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tapan Kadia

Showing results (1-10 of 286) with videos related to

Pageof 29
Sort By:
Current Oncology Reports|September 9, 2023
Approach to the Older Patient with Acute Myeloid LeukemiaMarkie Zimmer, Tapan Kadia
Current Treatment Options in Oncology|April 23, 2020
Individualizing Treatment for Newly Diagnosed Acute Myeloid LeukemiaPatrick K Reville, Tapan Kadia
Expert Review of Anticancer Therapy|June 20, 2020
Identifying effective drug combinations for patients with acute myeloid leukemiaMusa Yilmaz, Tapan Kadia, Farhad Ravandi
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Peripheral blasts on day 21 of induction chemotherapy in a patient with core binding factor acute myeloid leukemia: more than meets the eyeSameer A Parikh, Tapan Kadia, Elias Jabbour
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
More Versus Less Therapy for Older Adults With Acute Myeloid Leukemia: New Perspectives on an Old DebateHeidi D Klepin, Elihu Estey, Tapan Kadia
BMJ Case Reports|July 13, 2012
Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemiaHadley Sharp, David Grosshans, Tapan Kadia, et al.
Ejhaem|January 31, 2023
Aplastic anemia following the severe acute respiratory syndrome coronavirus-2 vaccineRodrick Babakhanlou, Tapan Kadia, Kelly Chien, et al.
Leukemia & Lymphoma|September 25, 2019
CPX-351 (vyxeos) in AMLMansour Alfayez, Hagop Kantarjian, Tapan Kadia, et al.
Cancer Management and Research|October 22, 2019
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient SelectionHussein A Abbas, Mansour Alfayez, Tapan Kadia, et al.
Blood Cancer Journal|June 10, 2022
Resistance to targeted therapies: delving into FLT3 and IDHSai Prasad Desikan, Naval Daver, Courtney DiNardo, et al.
Pageof 29

Showing results (1-10 of 286) with videos related to

Sort By:
Pageof 29
Current Oncology Reports|September 9, 2023
Approach to the Older Patient with Acute Myeloid LeukemiaMarkie Zimmer, Tapan Kadia
Current Treatment Options in Oncology|April 23, 2020
Individualizing Treatment for Newly Diagnosed Acute Myeloid LeukemiaPatrick K Reville, Tapan Kadia
Expert Review of Anticancer Therapy|June 20, 2020
Identifying effective drug combinations for patients with acute myeloid leukemiaMusa Yilmaz, Tapan Kadia, Farhad Ravandi
Clinical Lymphoma, Myeloma & Leukemia|August 17, 2010
Peripheral blasts on day 21 of induction chemotherapy in a patient with core binding factor acute myeloid leukemia: more than meets the eyeSameer A Parikh, Tapan Kadia, Elias Jabbour
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
More Versus Less Therapy for Older Adults With Acute Myeloid Leukemia: New Perspectives on an Old DebateHeidi D Klepin, Elihu Estey, Tapan Kadia
BMJ Case Reports|July 13, 2012
Cutaneous graft-versus-host disease after proton-based craniospinal irradiation for recurrent Philadelphia-positive acute lymphoblastic leukaemiaHadley Sharp, David Grosshans, Tapan Kadia, et al.
Ejhaem|January 31, 2023
Aplastic anemia following the severe acute respiratory syndrome coronavirus-2 vaccineRodrick Babakhanlou, Tapan Kadia, Kelly Chien, et al.
Leukemia & Lymphoma|September 25, 2019
CPX-351 (vyxeos) in AMLMansour Alfayez, Hagop Kantarjian, Tapan Kadia, et al.
Cancer Management and Research|October 22, 2019
Midostaurin In Acute Myeloid Leukemia: An Evidence-Based Review And Patient SelectionHussein A Abbas, Mansour Alfayez, Tapan Kadia, et al.
Blood Cancer Journal|June 10, 2022
Resistance to targeted therapies: delving into FLT3 and IDHSai Prasad Desikan, Naval Daver, Courtney DiNardo, et al.
Pageof 29